Selegiline Transdermal System (TDS) 6 mg/24 h

selegiline · Corium Innovations, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Selegiline Transdermal System (TDS) 6 mg/24 h, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy Subjects